Oxaliplatin exerts potent in vitro cytotoxicity in colorectal and pancreatic cancer cell lines and liver metastases

Anticancer Research

Volumn 20, Issue 5, 2000, Pages 3259-3264

  Kornmann, M ^a   Fakler, H ^a   Butzer, U ^a   Beger, H G ^a   Link, K H ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Colon cancer; Hepatic arterial infusion; Liver metastases; Pancreatic cancer; Regional chemotherapy

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; LEVAMISOLE; MITOMYCIN C; MITOXANTRONE; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; COLONY FORMATION; COLORECTAL CANCER; CONCENTRATION RESPONSE; CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; DRUG INHIBITION; DRUG POTENCY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IC 50; IN VITRO STUDY; LIVER METASTASIS; MALE; PANCREAS CANCER; PRIORITY JOURNAL;

AGED; ANTINEOPLASTIC AGENTS; CELL DIVISION; COLORECTAL NEOPLASMS; FEMALE; HT29 CELLS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; PANCREATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0033786068     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Oxaliplatin: A review of preclinical and clinical studies
2. Report on the pharmacokinetic of oxaliplatin in patients with normal and impaired renal function
3. Clinical trials referral resource. Clinical trials of single-agent oxaliplatin
4. Antitumor activity of 1-OHP in mice
5. Antitumor activity of a new platinum complex, oxalato (trans-1-1,2-diaminocyclohexane) platinum (II): New experimental data
6. Oxaliplatin: A review of its use in the management of metastatic colorectal cancer
7. Randomised multicenter trial of chronotherapy with oxaliplatin, fluorouracil and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy
8. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer
9. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie
10. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy
11. Hepatic arterial chemotherapy in metastatic colorectal patients
12. Regional chemotherapy of non-resectable liver metastases from colorectal cancer - Literature and institutional review
13. In vitro concentration response studies and in vitro phase II tests as the experimental basis for regional chemotherapeutic protocols
14. Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases
15. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery
16. Dose response treatment studies with two pancreatic carcinoma cell lines in vitro
17. Concentration and time dependence of the toxicity of fluorinated pyrimidines to HT29 cololectal carcinoma cells
18. Pancreatic cancer cells express interleukin-13 and -4 receptors and their growth is inhibited by Pseudomonas exotoxin coupled to interleukin-13 and -4
19. Regional chemotherapy directed by individual chemosensitivity testing in vitro: A prospective decision-aiding trial
20. Primary bioassay of human tumor stem cells
21. Activity of oxaliplatin against human tumor colony-forming units
22. Surgical treatment of liver metastases in patients with colorectal cancer
23. Intraarterial adjuvant chemotherapy after pancreaticoduodenectomy for pancreatic cancer: Significant reduction in occurrence of liver metastasis
24. Oxaliplatin: A new therapeutic option in colorectal cancer
25. Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel
26. Intracellular glutathione and cytotoxicity of platinum complexes
27. Etude pharmacocinetique de l'administration intraveineuse (iv) et intraarterielle hepatique (iah) de l'oxaliplatine (LOHP) chez des lapins New Zealand avec carcinome VX2 implante dans le foic